Bell International Laboratories, Inc
FDA inspection history in Eagan, Minnesota, 2023 to 2024
- 1
- Warning letter
- 1
- Form 483
- 1
- Close-out
Every document, by year
- Warning letter
- Form 483
- Close-out
2023: one Form 483; 2024: one warning letter.
The story so far
Built from the dates and citations on the documents themselves.
- 2023–24One Form 483 and one warning letter, at Eagan, Minnesota.
Cited most
Across all Bell International Laboratories observations on file
- 21 CFR 211.84Testing and approval or rejection of components, drug product containers, and closures2
- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.165Testing and release for distribution1
- 21 CFR 211.180General requirements1
- 21 CFR 211.188Batch production and control records1
The complete Bell International Laboratories file.
All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Eagan, Minnesota
One warning letter, one Form 483 and one close-out letter · 2023 to 2024 · 10 observations
Latest: Warning letter, Feb 15, 2024 →
Documents
3 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2024-02-15 | Warning letter Warning letter | Eagan, Minnesota | — | $99 |
| 2023-09-19 | 483 Form 483 | Eagan, Minnesota | 10 | $99 |
| Undated | Close-out Close-out letter | Eagan, Minnesota | — | $99 |
FEI number 3005574978 · most recent document Feb 15, 2024
About Bell International Laboratories, Inc
How many FDA Form 483s has Bell International Laboratories, Inc received?
FDA Intel has 1 Form 483 on file for Bell International Laboratories, Inc; the most recent is dated Sep 19, 2023.
When was Bell International Laboratories, Inc last inspected by FDA?
The most recent FDA inspection document on file for Bell International Laboratories, Inc is a Form 483 dated Sep 19, 2023, for the site in Eagan, Minnesota.
What did FDA cite at Bell International Laboratories, Inc?
The regulations cited most in the observations on file for Bell International Laboratories, Inc are 21 CFR 211.84 (Testing and approval or rejection of components, drug product containers, and closures), 2 times; 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 1 time; 21 CFR 211.165 (Testing and release for distribution), 1 time.
Has Bell International Laboratories, Inc received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Bell International Laboratories, Inc; the most recent is dated Feb 15, 2024.